BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa - Omicron - within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. <br /><br />WATCH MORE: https://thestartv.com/c/news<br />SUBSCRIBE: https://cutt.ly/TheStar<br />LIKE: https://fb.com/TheStarOnline
